Butalbital And Acetaminophen Tablet
Product Images NDC 68047-721

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Butalbital And Acetaminophen (NDC 68047-721). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Larken Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Butalbital Structure (Figure 01)

Chemical structure of butalbital, an active ingredient in ALLZITAL tablets containing butalbital and acetaminophen. The diagram shows a pyrimidine ring with keto and amine groups and attached hydrocarbon side chains.*

FDA Label Image

Acetaminophen Structure (Figure 02)

Chemical structure diagram showing a benzene ring with hydroxyl (OH) and acetamido (NHCOCH3) substituents, consistent with the structure of acetaminophen, one of the active ingredients in ALLZITAL tablets.*

FDA Label Image

Butalbital And Acetaminophen 50 mg 325 mg Label (Figure 03)

Label for ALLZITAL butalbital and acetaminophen tablets, 50 mg / 325 mg strength. The label shows product name, strength, and dosage form, along with distributor information for Larken Laboratories, Inc. It includes a barcode, quantity of 100 tablets, and warnings about habit-forming potential and storage instructions.*

FDA Label Image

Butalbital And Acetaminophen 25 mg 325 mg Label (Figure 04)

Label for ALLZITAL butalbital and acetaminophen tablets, 25 mg / 325 mg strength, in a 100-tablet bottle. The label includes the active ingredients, dosage form as oral tablets, and states the product is prescription only, distributed by Larken Laboratories, Inc., Canton, MS. Additional prescribing warnings and storage instructions are also visible.*

FDA Label Image

Figure 05

Packaging label for Allzital tablets containing 25 mg butalbital and 325 mg acetaminophen. The label indicates a prescription oral tablet form, distributed by Larken Laboratories, Inc., with a package size of 100 tablets. The label includes dosage and storage warnings and instructions for pharmacist dispensing.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.